Korean J Urol.
1960 Jan;1(1):55-58.
Clinical Study on Cases of Bladder Tumor
- Affiliations
-
- 1Department of Urology, Seoul National University, College of Medicine, Seoul, Korea.
Abstract
- 1. Author has reviewed 41 cases of bladder tumor treated at Urological Department of Seoul National University during the period of 3 years and 9 months from August 1954 to May 1958. The clinical studies on above cases revealed following findings. 2. There were no specific relationships between family histories, past histories and occupations of patients and bladder tumor. 3. Among the series, 3 were recurrent, another 3 cases were metastatic while the rest of cases (35) were primary tumors. 4. 21 cases were treated as the in-patients, 11 cases out of 21 cases were treated by surgical procedures and 10 cases were found to be contraindicated for the surgical procedure because of the advancement of the malignancy. 5. There were 31 males and 9 females, the ratio being 4:1. 6. The youngest age was 26 and oldest age was 76. 80.5% of series ranged from 40 years of age to 69 years. 7. The 87.8% of chief complaints were hematuria, 78.0% were painful urination,37.1% were frequency. 8. The predominant initial symptom was hematuria among 78.0% of cases. 9. Since the time lapsed from the initial onset to first hospital visit was 6 months to 2 years in 48.7% of series. It showed marked difference from the fact that 43% of series reported by Drinker in the America visited hospital within 3 months from the initial onset. 10. According to cystoscopic findings, there were 19 cases of non-infiltrating type and 19 cases of infiltrating type while 3 metastatic type, 2 solitary and 20 multiple cases were present 11. As to the localization of tumor, 46.3% of series were on lateral wall of the bladder. 12. Out of 11 cases treated surgically 3 cases were treated by total cystectomy combined with ureterosigmoidostomy, 4 cases were electro-coagulation and 4 cases were partial resection of the bladder. 13. It seems to be feasible that estrogen could be administrated per os as a conservative procedure for an inoperable case and also estrogen could be combined as a pre-and post-operative medication for a surgical case.
